Presentation The Structural Heart Disease Summit 2018 Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders? Presenter: Howard C. Herrmann June 22, 2018 REGISTER for free or LOG IN to view this content Structural Heart Presentation The Structural Heart Disease Summit 2018 Aortic Valve Up Next Presentation The Structural Heart Disease Summit 2018 Submassive PE, Paradoxical Embolism, Residual DVT, and Large PFO: Thrombolysis, Filter, or Both? Presenter: Horst Sievert June 22, 2018 More slides + Presentation The Structural Heart Disease Summit 2018 Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A) Presenter: Francesco Maisano June 22, 2018 Presentation The Structural Heart Disease Summit 2018 Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision Presenter: Axel Linke June 22, 2018 We Recommend
Presentation The Structural Heart Disease Summit 2018 Submassive PE, Paradoxical Embolism, Residual DVT, and Large PFO: Thrombolysis, Filter, or Both? Presenter: Horst Sievert June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A) Presenter: Francesco Maisano June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision Presenter: Axel Linke June 22, 2018